CoChat

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

Johnston, Brad C, Supina, Alison L, Ospina, Maria, Vohra, Sunita · 2007 · Cochrane Database of Systematic Reviews
Cited by 115

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Antibiotics alter the microbial balance within the gastrointestinal tract. Probiotics may prevent antibiotic-associated diarrhea (AAD) via restoration of the gut microflora. Antibiotics are prescribed frequently in children and AAD is common in this population. OBJECTIVES: To assess the efficacy and adverse effects of probiotics (any specified strain or dose) for the prevention of antibiotic-associated diarrhea in children. To assess adverse events associated with the use of probiotics when co-administered with antibiotics in children. SEARCH STRATEGY: MEDLINE, EMBASE, CENTRAL, CINAHL , AMED, and the Web of Science (inception to August 2006) were searched along with specialized registers including the Cochrane IBD/FBD Review Group, CISCOM, Chalmers PedCAM Research Register and trial registries from inception to 2005. Letters were sent to authors of included trials, nutra/pharmaceutical companies, and experts in the field requesting additional information on ongoing or unpublished trials. Conference proceedings, dissertation abstracts, and reference lists from included and relevant articles were hand searched. SELECTION CRITERIA: Randomized, parallel, controlled (placebo, active, or no treatment) trials comparing co-administered probiotics with antibiotics for the prevention of diarrhea secondary to antibiotic use in children (0 to 18 years). DATA COLLECTION AND ANALYSIS: Methodological quality assessment and data extraction were conducted independently by two authors (BCJ, AS). Dichotomous data (incidence of diarrhea, adverse events) were combined using pooled relative risks, and continuous data (mean duration of diarrhea, mean daily stool frequency) as weighted mean differences, along with their corresponding 95% confidence intervals. Adverse events were summarized using risk difference. For overall pooled results on the incidence of diarrhea, a priori sensitivity analyses included per protocol versus intention to treat, random versus fixed effects, and methodological quality criterion. Subgroup analysis were conducted on probiotic strain, dose, definition of antibiotic-associated diarrhea, and antibiotic agent. MAIN RESULTS: Ten studies met the inclusion criteria. Trials included treatment with either Lactobacilli spp., Bifidobacterium spp., Streptococcus spp., or Saccharomyces boulardii alone or in combination. Six studies used a single strain probiotic agent and four combined two probiotic strains. The per protocol analysis for 9/10 trials reporting on the incidence of diarrhea show statistically significant results favouring probiotics over active/non active controls (RR 0.49; 95% CI 0.32 to 0.74). However, intention to treat analysis showed non-significant results overall (RR 0.90; 95% CI 0.50 to 1.63). Five of ten trials monitored for adverse events (n = 647); none reported a serious adverse event. AUTHORS' CONCLUSIONS: Probiotics show promise for the prevention of pediatric AAD. While per protocol analysis yields treatment effect estimates that are both statistically and clinically significant, as does analysis of high quality studies, the estimate from the intention to treat analysis was not statistically significant. Future studies should involve probiotic strains and doses with the most promising evidence (e.g., Lactobacillus GG, Lactobacillus sporogenes, Saccharomyces boulardii at 5 to 40 billion colony forming units/day). Research done to date does not permit determination of the effect of age (e.g., infant versus older children) or antibiotic duration (e.g., 5 days versus 10 days). Future trials would benefit from a validated primary outcome measure for antibiotic-associated diarrhea that is sensitive to change and reflects what treatment effect clinicians, parents, and children consider important. The current data are promising, but it is premature to routinely recommend probiotics for the prevention of pediatric AAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd004827.pub2

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 58

  1. Arvola, 1999, Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study, Pediatrics, 104, e64, 10.1542/peds.104.5.e64 · DOI · Paper page
  2. Benhamou, 1999, Antibiotic-associated diarrhoea in children: A computer monitored double-blind outpatients trial comparing a protective and a probiotic agent, Med Chir Dig, 28, 163
  3. Contardi, 1991, Oral bacterial therapy in prevention of antibiotic-induced diarrhea in childhood, Clin Ter, 136, 409
  4. Erdeve, 2004, The probiotic effect of Saccharomyces boulardii in a pediatric age group, J Trop Pediatr, 50, 234, 10.1093/tropej/50.4.234 · DOI · Paper page
  5. Jirapinyo, 2002, Prevention of antibiotic-associated diarrhea in infants by probiotics, J Med Assoc Thai, 85, s739
  6. Kotowska, 2005, Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial, Aliment Pharmacol Ther, 21, 583, 10.1111/j.1365-2036.2005.02356.x · DOI · Paper page
  7. LaRosa, 2003, Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children: A multicentric double-blind vs placebo study, Minerva Pediatr, 55, 447
  8. Tankanow, 1990, A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea, DICP, 24, 382, 10.1177/106002809002400408 · DOI · Paper page
  9. Vanderhoof, 1999, Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children, J Pediatr, 135, 564, 10.1016/S0022-3476(99)70053-3 · DOI · Paper page
  10. Brunser, 2006, Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment, Pediatr Res, 59, 451, 10.1203/01.pdr.0000198773.40937.61 · DOI
  11. Chapoy, 1985, Treatment of infantile diarrhea: controlled trial of Saccharomyces boulardii, Ann Pediatr (Paris), 32, 561
  12. Czerwionka-Szaflarska, 2006, Effect of probiotic bacteria supplementation on the tolerance of helicobacter pylori eradication therapy in children and youth, Pediatria Polska, 81, 334
  13. Erdeve, 2005, Saccaromyces boulardii and antibiotic-assoiciated diarrhoea in children, Aliment Pharmacol Ther, 21, 1507, 10.1111/j.1365-2036.2005.02498.x · DOI
  14. Lei, 2006, Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: an intervention study in northern Ghana, Int J Food Microbiol, 110, 246, 10.1016/j.ijfoodmicro.2006.04.022 · DOI
  15. McFarland, 2005, Can Saccharomyces boulardii prevent antibiotic-associated diarrhea in children?, Nat Clin Pract Gastroenterol Hepatol, 2, 262, 10.1038/ncpgasthep0188 · DOI
  16. Michielutti, 1996, Clinical assessment of a new oral bacterial treatment for children with acute diarrhea, Minerva Med, 87, 545
  17. Schrezenmeir, 2004, Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections, Clin Pediatr (Phila), 43, 239, 10.1177/000992280404300305 · DOI · Paper page
  18. Siitonen, 1990, Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea, Ann Med, 22, 57, 10.3109/07853899009147243 · DOI · Paper page
  19. Srinivasan, 2006, Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children, J Pediatr Gastroenterol Nutr, 42, 171, 10.1097/01.mpg.0000189335.62397.cf · DOI · Paper page
  20. Sykora, 2005, Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study, J Clin Gastroenterol, 39, 692, 10.1097/01.mcg.0000173855.77191.44 · DOI · Paper page
  21. Thomas, 2001, Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial, Mayo Clin Proc, 76, 883, 10.4065/76.9.883 · DOI · Paper page
  22. Witsell, 1995, Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: a prospective randomized trial, J Otolaryngol, 24, 230
  23. Zoppi, 2001, Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone, Curr Ther Res, 62, 418, 10.1016/S0011-393X(01)89006-8 · DOI · Paper page
  24. Duman, 2005, Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication, Eur J Gastroenterol Hepatol, 17, 1357, 10.1097/00042737-200512000-00015 · DOI · Paper page
  25. Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 · DOI · Paper page
  26. Cremonini, 2002, Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhea, Aliment Pharmacol Ther, 16, 1461, 10.1046/j.1365-2036.2002.01318.x · DOI · Paper page
  27. D'Souza, 2002, Probiotics in the prevention of antibiotic associated diarrhoea: meta-analysis, BMJ, 324, 1361, 10.1136/bmj.324.7350.1361 · DOI · Paper page
  28. Vecchi, 2006, Lactobacillus sporogenes or bacillus coagulans: Misidentification or mislabelling?, International Journal of Probiotics and Prebiotics, 1, 3
  29. Dickersin, 1994, Indentifying relevant studies for systematic reviews, BMJ, 309, 1286, 10.1136/bmj.309.6964.1286 · DOI · Paper page
  30. Djulbegovic, 2000, The uncertainty principle and industry-sponsored research, Lancet, 356, 635, 10.1016/S0140-6736(00)02605-2 · DOI · Paper page
  31. Duval, 2001, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x · DOI · Paper page
  32. Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
  33. Elstner, 1983, Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children, Pediatr Infect Dis, 2, 364, 10.1097/00006454-198309000-00006 · DOI · Paper page
  34. Fontana, 1989, Bowel frequency in healthy children, Acta Paediatr Scand, 78, 682, 10.1111/j.1651-2227.1989.tb11126.x · doi:10.1111/j.1651-2227.1989.tb11126.x
  35. Gibson, 1998, Dietary modulation of the human gut microflora using prebiotics, Br J Nutr, 80, S209, 10.1017/S0007114500006048 · DOI · Paper page
  36. Girard, 2003, Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats, Dig Dis Sci, 48, 770, 10.1023/A:1022801228938 · DOI
  37. Gogate, 2005, Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children, Indian J Med Res, 122, 518
  38. Goldin, 1998, Health benefits of probiotics, Br J Nutr, 80, S203, 10.1017/S0007114500006036 · DOI · Paper page
  39. Hata, 1988, Meningitis caused by bifidobacterium in an infant, Pediatr Infect Dis J, 7, 669, 10.1097/00006454-198809000-00018 · DOI · Paper page
  40. Havenaar, 1992, Probiotics: a general view. In: Wood BJB, editor. Lactic acid bacteria in health and disease. Vol 1 of series, The lactic acid bacteria, Amsterdam: Elsevier Applied Science Publishers
  41. Heritier, 2003, Inclusion of patients in clinical trial analysis: the intention-to-treat principle, Med J Aust, 179, 438, 10.5694/j.1326-5377.2003.tb05627.x · DOI · Paper page
  42. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  43. Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 · DOI · Paper page
  44. Mackay, 1999, Lactobacillus endocarditis caused by a probiotic organism, Clin Microbiol Infect, 5, 290, 10.1111/j.1469-0691.1999.tb00144.x · DOI · Paper page
  45. Madsen, 2001, The use of probiotics in gastrointestinal disease, Can J Gastroentrol, 15, 817, 10.1155/2001/690741 · DOI · Paper page
  46. McFarland, 1998, Epidemiology, risk factors and treatments for antibiotic-associated diarrhea, Dig Dis, 16, 292, 10.1159/000016879 · DOI · Paper page
  47. McMahon, 2002, Study control, violators, inclusion criteria and defining explanatory and pragmatic trials, Stat Med, 21, 1365, 10.1002/sim.1120 · DOI · Paper page
  48. Piarroux, 1999, Are live saccharomyces yeasts harmful to patients?, Lancet, 353, 1851, 10.1016/S0140-6736(99)02001-2 · DOI
  49. Rautio, 1999, Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG, Clin Infect Dis, 28, 1159, 10.1086/514766 · DOI · Paper page
  50. Raza, 1995, Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan, Pediatr Infect Dis J, 14, 107, 10.1097/00006454-199502000-00005 · DOI · Paper page
  51. Roberfroid, 1998, Prebiotics and synbiotics: concepts and nutritional properties, Br J Nutr, 80, S197, 10.1017/S0007114500006024 · DOI · Paper page
  52. Saavedra, 1999, Probiotics plus antibiotics: regulating our bacterial environment, J Pediatr, 135, 535, 10.1016/S0022-3476(99)70046-6 · DOI
  53. Sazawal, 2006, Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials, Lancet Infect Dis, 6, 374, 10.1016/S1473-3099(06)70495-9 · DOI · Paper page
  54. Schrezenmeir, 2001, Probiotics, prebiotics, and synbiotics -- approaching a definition, Am J Clin Nutr, 73, 361S, 10.1093/ajcn/73.2.361s · DOI · Paper page
  55. Schulz, 1995, Emperical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.273.5.408 · doi:10.1001/jama.273.5.408
  56. Turck, 2003, Incidence and risk factors for of oral antibiotic-associated diarrhea in an outpatient pediatric population, J Pediatr Gastroenterol Nutr, 37, 22, 10.1097/00005176-200307000-00004 · doi:10.1097/00005176-200307000-00004 · Paper page
  57. Wistrom, 2001, Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study, J Antimicrob Chemother, 47, 43, 10.1093/jac/47.1.43 · DOI · Paper page
  58. Johnston, 2006, Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials, CMAJ, 175, 377, 10.1503/cmaj.051603 · DOI · Paper page

Cited by

See all 115

Metadata

Authors
Johnston, B. C., Supina, A. L., Ospina, M., & Vohra, S.
Venue
Cochrane Database of Systematic Reviews
Published
2007-04-18
Issue
2
Pages
CD004827-CD004827
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4239724737
Cited by
115
References
11
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics for the prevention of pediatric antibiotic-associated diarrhea. https://app.cochat.ai/papers/10.1002/14651858.cd004827.pub2
The paper
Johnston, B. C., Supina, A. L., Ospina, M., & Vohra, S. (2007). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004827.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.